Skip to main content
. 2015 Jun 15;128(12):2363–2373. doi: 10.1242/jcs.169466

Fig. 8.

Fig. 8.

Reduced infectivity of GFP–TcRab32 mutant trypomastigotes. (A) Growth rate of epimastigotes expressing dominant-negative (DN) GFP–TcRab32 in comparison to GFP-expressing epimastigotes (GFP). Values are means±s.d. from three independent experiments. (B,C) The effect of expression of dominant-negative GFP–TcRab32 (DN) on the invasion by trypomastigotes of host cells in vitro in comparison with wild-type trypomastigotes (WT) or GFP-expressing trypomastigotes (GFP). Values are mean±s.d. (n=3). *Differences are statistically significant, P<0.05 (one way ANOVA with Bonferroni post-hoc test).